Introduction: Welcome to Medicines and Drug Action!
Welcome to this revision guide for A2 6: Microbiology. In this chapter, we explore how medicines are discovered, tested, regulated, and how they behave inside the human body. Whether you love pharmacology or find the science of drugs a bit overwhelming, do not worry! We will break down every concept step-by-step using clear analogies, memory tricks, and easy-to-digest explanations.
Quick Review: Medicines are chemical substances used to treat, cure, prevent, or diagnose diseases. Let's look at where they come from and how they reach the patient safely.
---1. Methods of Developing New Drugs
Where do brand-new medicines come from? Scientists use a variety of strategies to identify potential new treatments:
1. Accidental Discovery: Some of our greatest drugs were discovered by chance. The most famous example is penicillin, discovered by Alexander Fleming when mould accidentally contaminated his bacterial culture plates and killed the bacteria around it.
2. High Demand for Particular Medicines: When an urgent health crisis emerges (such as antibiotic resistance or a global viral outbreak), research funding and scientific focus pivot rapidly to develop targeted solutions.
3. Deriving Modern Drugs from Traditional Remedies: Many communities have used herbal extracts for centuries. Modern scientists isolate the exact active chemical compound responsible for the healing effect (for example, isolating aspirin from willow bark).
4. Observing Wildlife and Plants: Tropical rainforests boast incredible biodiversity. Animals often consume specific plants when unwell (zoopharmacognosy), giving researchers vital clues about medicinal properties.
5. Chemical Fingerprinting Technology: Rather than testing plants blindly, modern high-tech screening uses chemical fingerprinting to rapidly scan and identify active medicinal molecules in natural samples.
6. Genetics: Advances in genomics allow scientists to pinpoint faulty genes causing diseases and design tailored medicines to counteract those specific genetic defects.
7. Studying Pathogen-Host Interactions: By observing how pathogenic microorganisms invade and interact with human host cells, researchers design drugs that physically block receptors or disable enzymes the pathogen needs to survive.
8. Synthetic Drugs in the Laboratory: Organic chemists can design and synthesise entirely new molecules from scratch using computer modelling and chemical synthesis.
Key Takeaway: Drug discovery combines natural exploration (plants, fungi, traditional remedies) with advanced modern technology (genetics, chemical fingerprinting, and synthetic chemistry).
---2. Drug Nomenclature and Classification
Naturally Derived Medicines
Many essential medicines come from nature. Key examples you should know include:
• Penicillin: Antibiotic derived from the fungus Penicillium.
• Aspirin: Analgesic originally derived from willow bark (salicin).
• Taxol (Paclitaxel): Chemotherapy drug derived from the bark of the Pacific Yew tree.
• Digitoxin: Heart medication derived from the foxglove plant.
• Heparin: Anticoagulant naturally extracted from animal tissues.
• Yondelis: Anti-cancer medicine extracted from marine organisms (sea squirts).
• Tiotropium: Bronchodilator developed from natural alkaloid plant compounds.
How Medicines are Named (Nomenclature)
Every medicine typically has three distinct names:
1. Chemical Name: Describes the exact molecular structure and functional groups according to international chemical rules (e.g., 2-acetoxybenzoic acid).
2. Generic Name: The official, non-proprietary medical name given to the active compound (e.g., aspirin or paracetamol).
3. Trade (Brand) Name: The commercial name given by the pharmaceutical company that manufactures it (e.g., Disprin® or Panadol®).
The ATC Classification System
Medicines are globally categorised using the Anatomical Therapeutic Chemical (ATC) classification system managed by the World Health Organization (WHO). This divides drugs into different levels based on:
• The Anatomical organ or system they act on (e.g., Cardiovascular system, Nervous system).
• The Therapeutic intent or main effect (e.g., Analgesic, Anti-inflammatory).
• The Chemical characteristics and pharmacological subgroup of the drug.
Key Takeaway: A medicine has a chemical name (its structure), a generic name (standard active ingredient), and a trade name (brand). The ATC system groups drugs by organ, therapy, and chemical class.
---3. From Concept to Consumer: The Drug Development Pipeline
Stages of Development
Developing a medicine takes many years and involves rigorous safety stages:
Stage 1: Pre-Discovery & Extraction/Refinement
The biological target is identified, active compounds are discovered, and extraction and purification processes are developed to produce a pure, stable chemical.
Stage 2: Preclinical Testing (In Vitro and In Vivo)
• In vitro testing: Carried out in lab glassware/test tubes using cell cultures or tissue samples.
• In vivo testing: Carried out in living animal models to observe how the drug works in a complete biological system.
Pharmacology and Toxicology Testing: Researchers determine safety and dosing thresholds:
• Effective Dose \(50\) (\(ED_{50}\)): The dose required to produce the desired therapeutic effect in \(50\%\) of the test population.
• Lethal Dose \(50\) (\(LD_{50}\)): The dose that is fatal to \(50\%\) of the test population in animal studies.
• Therapeutic Index (\(TI\)): A measure of drug safety calculated as:
\(\text{Therapeutic Index} = \frac{LD_{50}}{ED_{50}}\)
A high therapeutic index means there is a wide safety margin between the effective dose and a dangerous dose.
Stage 3: Clinical Trials (Human Testing)
Clinical trials must follow strict protocols to ensure that the only factor changing is the medical intervention:
• Control Groups & Placebos: Comparing the new medicine against an inactive dummy pill (placebo) or the current gold-standard treatment.
• Randomisation & Blinding: In a double-blind trial, neither the patient nor the doctor knows who receives the real drug, preventing bias.
• Cohort Grouping: Results from different patient cohorts and multiple trial centres are pooled to increase the evidence base and statistical reliability.
Ethical Issues, Patient Consent, and Regulation
• Informed Consent: Patients must be fully briefed on possible risks, benefits, and trial procedures before voluntarily agreeing to participate.
• Manufacturer Responsibilities: Drug companies must maintain Good Manufacturing Practice (GMP), guarantee batch purity, report all safety data honestly, and ensure fair pricing/supply.
• UK Regulatory Bodies: The MHRA (Medicines and Healthcare products Regulatory Agency) evaluates all trial data to verify quality, safety, and efficacy before granting a product licence (marketing authorisation).
Key Takeaway: Before reaching the public, a drug moves from in vitro and in vivo lab testing through controlled, randomised human clinical trials to establish its \(ED_{50}\), \(LD_{50}\), and clinical efficacy.
---4. Formulations, Safety, and Monitoring
Drug Formulations
A medicine's formulation is the physical form in which it is prepared for administration. Each formulation has distinct pros and cons:
• Tablets and Capsules (Oral): Convenient, non-invasive, and have a long shelf life. However, they act slowly and may be broken down by stomach acid or the liver.
• Injections (Intravenous/Intramuscular): Rapid absorption, high bioavailability, and useful in emergencies. However, they are invasive, require sterile equipment, and can be painful.
• Inhalers (Respiratory): Deliver medication directly to lung tissue with minimal whole-body side effects (e.g., asthma relief). However, they require proper breathing technique.
• Topical (Creams, Ointments, Transdermal Patches): Target local areas directly on the skin with low systemic toxicity, but absorption through the skin barrier can be slow and variable.
Side Effects, Contraindications, and Safety Monitoring
• Side Effects: Unintended, secondary biological effects that occur alongside the therapeutic effect (e.g., drowsiness caused by antihistamines).
• Contraindications: Specific health conditions, patient factors, or concurrent medications that make using a particular drug dangerous or inadvisable (e.g., prescribing aspirin to someone with active stomach ulcers).
• Black Triangle Drugs (\(\blacktriangledown\)): Newly licensed medicines that are subject to intensive safety surveillance.
• The Yellow Card Scheme: A UK system run by the MHRA that allows healthcare professionals and patients to report suspected adverse drug reactions (ADRs), ensuring emerging safety hazards are spotted quickly after a drug is launched.
Key Takeaway: Formulations dictate how quickly and comfortably a drug works. Even after licensing, safety is monitored continuously via the Yellow Card Scheme, especially for Black Triangle medicines.
---5. Pharmacodynamics and Pharmacokinetics
To master pharmacology, remember this simple distinction:
• Pharmacodynamics: What the drug does to the body.
• Pharmacokinetics: What the body does to the drug (ADME).
Pharmacodynamics (Mechanism of Action)
Pharmacodynamics examines how chemicals exert their biological effects. Drugs bind to specific sites of action (target receptors on cell membranes, specific enzymes, ion channels, muscle tissues, blood components, or the central nervous system). Their ability to bind depends directly on their molecular structure and functional groups, fitting like a key in a lock.
Pharmacokinetics: The ADME Journey
Pharmacokinetics determines the right dose to achieve the desired therapeutic effect without causing toxicity. It covers four major phases:
1. Administration: The route by which the drug enters the body (oral, intravenous, inhalation, topical, sublingual).
2. Absorption: How the active substance is assimilated into the bloodstream. This involves processes like the disintegration of a solid tablet, dissolution of the active chemical in digestive fluids, or direct absorption across cell membranes into capillaries.
3. Distribution: How the drug is transported throughout the body's tissues via the bloodstream. Distribution depends on several crucial factors:
• Extent of blood supply: Well-perfused organs (heart, liver, kidneys) receive the drug quickly, while poorly perfused tissues (fat, bone) take longer.
• Plasma protein binding: Drugs can bind reversibly to albumin in the blood. Only the "free" (unbound) drug can leave the blood vessels to exert its effect.
• Tissue binding: Some drugs accumulate in specific tissues (such as lipid-soluble drugs settling in adipose tissue).
• pH Differences: The pH of local body fluids affects whether a drug molecule is ionised or unionised, altering how easily it crosses lipid membranes.
4. Metabolism: The chemical conversion of the drug into different compounds (metabolites), primarily carried out by enzymes in the liver. Metabolism usually inactivates the drug and makes it more water-soluble for removal. Factors affecting metabolism include genetics, age, liver health, and interactions with other medicines.
5. Elimination (Excretion): The irreversible removal of the drug and its metabolites from the body. The main route is renal excretion via the kidneys into urine, but elimination also occurs through bile/faeces, sweat, and exhaled air. Elimination rates vary between individuals based on kidney function, age, and hydration levels.
Key Takeaway: Remember the acronym ADME (Administration/Absorption, Distribution, Metabolism, Elimination) for pharmacokinetics, while pharmacodynamics describes the target-site interactions driven by chemical structure and functional groups.
---Quick Summary Checklist for Revision
Before moving on to the next topic, make sure you can:
✔ List methods of finding new drugs (from traditional plants to modern chemical fingerprinting and genetics).
✔ Explain the difference between chemical, generic, and trade names, and describe the ATC system.
✔ Describe the development pipeline from preclinical testing (\(ED_{50}\), \(LD_{50}\), \(TI\)) to controlled clinical trials.
✔ Define the roles of the MHRA, the Yellow Card Scheme, and Black Triangle (\(\blacktriangledown\)) drugs.
✔ Compare formulations (oral, injection, topical, inhaler) and explain contraindications.
✔ Clearly differentiate between Pharmacodynamics (drug mechanism on target sites) and Pharmacokinetics (ADME journey).